XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

Post by Anklebiter42on Nov 23, 2021 10:36am

157 Views

Post# 34156861

Throw some shares in the water. See what happens.

Anyone who thinks that XORTX is a garbage stock should throw some shares "in the water." You will find out quickly that there are sharks in the water. Stay long and strong. As for me, I will be on the 40th like a vulture waiting to feast on Spacelab's Xortx shares.

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it